Aptevo Therapeutics (APVO) Cash & Current Investments (2015 - 2026)
Aptevo Therapeutics (APVO) reported Cash & Current Investments of $9.8 million for Q2 2026, up 4.1% from $9.41 million a year earlier but down 32.6% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Cash & Current Investments (2015 - 2026) Analysis & Trends
At the end of FY2025, Aptevo Therapeutics posted Cash & Current Investments of $21.62 million, up 148.1% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of -12.7% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $8.71 million in FY2024 (-48.5%), $16.9 million in FY2023 (-25.3%), $22.64 million in FY2022 (-51.1%) and $46.3 million in FY2021 (+8.9%).
- Five-year quarterly Cash & Current Investments spans a low of $2.14 million in Q1 2025 and a high of $53.38 million in Q3 2021.
- Year over year, Cash & Current Investments has now increased in each of the last five quarters, with growth averaging 91.6% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was Q1 2026 (growth of 579.1%); the low point was Q1 2025 (a decline of 79.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.53 million (Q1 2026), $21.62 million (Q4 2025) and $21.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Aptevo Therapeutics | 2.50 Mn | -64.50 Mn | - | 9.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.80 Mn |
| Mar 31, 2026 | 14.53 Mn |
| Dec 31, 2025 | 21.62 Mn |
| Sep 30, 2025 | 21.06 Mn |
| Jun 30, 2025 | 9.41 Mn |
| Mar 31, 2025 | 2.14 Mn |
| Dec 31, 2024 | 8.71 Mn |
| Sep 30, 2024 | 7.75 Mn |
| Jun 30, 2024 | 8.07 Mn |
| Mar 31, 2024 | 10.25 Mn |
| Dec 31, 2023 | 16.90 Mn |
| Sep 30, 2023 | 19.11 Mn |
| Jun 30, 2023 | 21.01 Mn |
| Mar 31, 2023 | 25.33 Mn |
| Dec 31, 2022 | 22.64 Mn |
| Sep 30, 2022 | 22.58 Mn |
| Jun 30, 2022 | 29.98 Mn |
| Mar 31, 2022 | 36.25 Mn |
| Dec 31, 2021 | 46.30 Mn |
| Sep 30, 2021 | 53.38 Mn |
API Access
Aptevo Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();